Recent studies have found that versions of the AAQ
that are tailored to problem areas better capture experiential avoidance specific to the problem behavior better than the AAQ
alone (e.g., Houghton et al.
What does the Acceptance and Action Questionnaire (AAQ
II) really measure?
Dado que existe una adaptacion al espanol del AAQ
se decidio usarla en la presente investigacion y se determino utilizar las tres dimensiones propuestas por dicho autor.
The original item pool of the initial AAQ
included 85 items.
Recent studies have shown that the AAQ-II has better psychometric properties and a clearer factor structure than the first AAQ
version (Bond et al., 2011).
By injecting AAQ
into their eyes, researchers reported that light sensitivity in the eyes had been restored, with the mice's pupils contracting in bright light.
binds to ion channels in retina cells and alters the flow of ions in response to light, mimicking how normal rods and cone cells react to light and activate neurons.
Sin embargo, a pesar de esta diferencia, los resultados concuerdan con los estudios anteriores al discriminar entre el grupo clinico y no clinico; por ejemplo, al traducir la primera version del AAQ
, Barraca (2004) obtuvo una media de 34.61 para el grupo no clinico y una media de 44.71 para el clinico.
In spite of promising data, some have expressed concern about perceived shortcomings of the AAQ
and the limitations of self-report measures in general (for a review, see Chawla & Ostafin, 2007).
The Acceptance and Action Questionnaire (AAQ
; Hayes et al., 2004) has been the most widely used measure of experiential avoidance and psychological inflexibility and has proven to be broadly useful because of its noticeable external validity.
The victim, identified as AAQ
, was riding his bike accompanied by his friend OAH, 15, Brigadier Mohammad Ahmad Bin Ghanim Al Kaabi, Commander Chief of Fujairah police, told Gulf News yesterday.
The chemical, called AAQ
, acts by making the remaining, normally "blind" cells in the retina sensitive to light, said lead researcher Richard Kramer, UC Berkeley professor of molecular and cell biology.